Ethyl Isocyanoacetate CAS 2999-46-4 Pite > 99.0% (GC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Ethyl Isocyanoacetate (CAS: 2999-46-4) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Non Chimik | Isocyanoacetate etil |
Sinonim | Estè etil asid isocyanoacetic |
Nimewo CAS | 2999-46-4 |
Nimewo CAT | RF-PI2193 |
Estati Stock | Nan Stock, Kapasite Pwodiksyon 300MT / Ane |
Fòmil molekilè | C5H7NO2 |
Pwa molekilè | 113.11 |
Pwen bouyi | 194.0 ~ 196.0 ℃ (lit.) |
Dansite | 1.035 g/mL nan 25℃ (lit.) |
Sere anba gaz inaktif | Sere anba gaz inaktif |
Sansib | Limyè sansib, imidite sansib, chalè sansib |
Solibilite | Miscible ak Solvang òganik.Yon ti kras melanje ak dlo |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Likid jòn limyè a mawon |
Pite / Metòd analiz | >99.0% (GC) |
Endèks refraktif n20/D | 1.4150 ~ 1.4230 |
Enpurte total | <1.00% |
Enfrawouj Spectrum | Konfòm ak estrikti |
Spectre proton RMN | Konfòm ak estrikti |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè famasetik |
Pake: Fliyò boutèy, 25kg/tanbou, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
Ethyl Isocyanoacetate (CAS: 2999-46-4) yo itilize kòm entèmedyè pharmaceutique ak òganik sentèz, entèmedyè Flumazenil (Anexate).Ethyl Isocyanoacetate se yon synthon cyclization ki itilize pou prepare pirol, oksazolin, benzodyazepin, oxazol ak imidazol.Ethyl isocyanoacetate ka itilize pou prepare pirol, 1,2 oksazolin, benzodyazepin, oxazol ak imidazol.Ethyl Isocyanoacetate se yon matyè premyè pou divès kalite API ak entèmedyè API, egzanp nan sentèz dérivés Benzodiazepine, oxazolines, Plinabulin ak nouvo ajan anti-bakteri.Aplikasyon Novel segondè kristalinite òganik semi-conducteurs;Materyèl demaraj kle pou sentèz dérivés Imidazopyrazinone ki anpeche Tankyrase;Kle matyè premyè pou sentèz koloran ftalosyanin tèmik solubilite ki kontwole;Kle matyè premyè pou sentèz Imrecoxib, yon nouvo inibitè COX-2 selektif pou tretman artroz;Materyèl bwit nan sentèz roman inibitè Epatit C.